kabutan

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.(2395) Summary

2395
TSE Prime
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
1,422
JPY
+7
(+0.49%)
Apr 28, 3:30 pm JST
8.93
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
16.6
PBR
1.12
Yield
3.52%
Margin Trading Ratio
5.83
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,427 JPY 8.95 USD
Previous Close Apr 27
1,415 JPY 8.87 USD
High Apr 28, 9:00 am
1,430 JPY 8.97 USD
Low Apr 28, 1:09 pm
1,407 JPY 8.83 USD
Volume
234,900
Trading Value
0.33B JPY 2.09M USD
VWAP
1416.7 JPY 8.9 USD
Minimum Trading Value
142,200 JPY 893 USD
Market Cap
0.06T JPY 0.37B USD
Number of Trades
583
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Slightly High
1-Year Average
833
1-Year High May 1, 2025
5,267
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 18,000 827,600 45.98
Apr 17, 2026 25,800 798,000 30.93
Apr 10, 2026 26,400 825,000 31.25
Apr 3, 2026 75,400 850,400 11.28
Mar 27, 2026 78,400 843,800 10.76
Company Profile
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is the domestic leader in preclinical testing services. The company offers services from basic research to contract testing, with a focus on pharmaceutical formulations. It is also involved in regenerative medicine.
Sector
Services
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. primarily operates in the CRO (Contract Research Organization) business, supporting pharmaceutical development. The company also engages in translational research, leveraging its proprietary nasal drug delivery technology and nurturing basic knowledge and technologies from universities and biotech ventures into viable businesses. Additionally, as part of its Medipolis project (a social benefit creation initiative), the company operates geothermal power generation and accommodation facilities utilizing its property in Ibusuki City, Kagoshima Prefecture.